{
    "2021-04-06": [
        [
            {
                "time": "2021-04-01",
                "original_text": "医药生物行业：为什么说智飞生物二季度有望迎来亮眼表现？",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "二季度",
                        "亮眼表现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "医药行业2021年4月投资月报：把握一季报最佳反弹窗口期 加配低估值且高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "医药行业周报：当前是反弹最佳窗口期 加配低估值高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "反弹窗口期",
                        "低估值",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "医药行业每周医览药闻：从2020年财报看国内创新药行业发展",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020年财报",
                        "创新药",
                        "发展"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "东吴证券--医药生物行业：为何近期医疗服务、医美大幅上涨？【行业研究】",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医药生物",
                        "医疗服务",
                        "医美",
                        "上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗服务",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "固定收益月报：进入业绩驱动",
                "features": {
                    "keywords": [
                        "固定收益",
                        "业绩驱动"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "2021年医药行业4月策略报告：Q1业绩高成长是股价核心催化剂",
                "features": {
                    "keywords": [
                        "医药行业",
                        "Q1业绩",
                        "高成长",
                        "股价",
                        "催化剂"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}